Omeros reported $439.82M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acelrx Pharmaceuticals ACRX:US USD 7.89M 2M
Adma Biologics ADMA:US USD 141.37M 1.56M
Aerie Pharmaceuticals AERI:US USD 312.59M 458K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Cytokinetics CYTK:US USD 610.73M 411.31M
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 807.82M 491K
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Knight Therapeutics Inc GUD:CN CAD 39.06M 849K
Omeros OMER:US USD 439.82M 125.46M
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Regulus Therapeutics RGLS:US USD 4.48M 32K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M